Coronary atherosclerotic heart disease
Conditions
Interventions
Resting group:PBS solution
Not adding medicine group:ADP or AA stimulation
Adding medicine group:Adding SAA
Sponsors
Lishui People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) He is over 18 years old and has signed an informed consent form; 2) Need to take dual antiplatelet drugs (aspirin+clopidogrel), and have taken them for more than 5-7 days before the platelet aggregation rate test; 3) Willing to participate in this study.
Exclusion criteria
Exclusion criteria: 1) Hemodynamic instability; 2) Severe hepatic and renal insufficiency, suspected or diagnosed as malignant tumor and being treated, severe infection, HIV/AIDS; 3) History of hematological diseases or bleeding tendency, history of surgery within half a year, and hemorrhagic diseases (such as upper gastrointestinal bleeding and cerebral hemorrhage) diagnosed within half a year; 4) Platelet count exceeds the normal range ; 5) Refuse to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet activation rate;Maximum platelet aggregation rate; | — |
Countries
China
Contacts
Public ContactChunlai Zeng
Lishui People's Hospital
Outcome results
None listed